hexamethylene bisacetamide has been researched along with B16 Melanoma in 3 studies
N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ickowicz Schwartz, D | 1 |
Gozlan, Y | 1 |
Greenbaum, L | 1 |
Babushkina, T | 1 |
Katcoff, DJ | 1 |
Malik, Z | 1 |
Orlow, SJ | 2 |
Chakraborty, AK | 2 |
Pawelek, JM | 2 |
Boissy, RE | 1 |
3 other studies available for hexamethylene bisacetamide and B16 Melanoma
Article | Year |
---|---|
Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.
Topics: Acetamides; Aminolevulinic Acid; Animals; Antineoplastic Agents; Blotting, Western; Butyrates; Cell | 2004 |
Membrane glycoproteins common to vesicles and melanosomes in mouse melanoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Acetamides; Animals; Female; Gene Expression Regulation, Neoplastic; Im | 1992 |
Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers.
Topics: 1-Methyl-3-isobutylxanthine; Acetamides; Animals; Butyrates; Butyric Acid; Cell Transformation, Neop | 1990 |